Pharmaceutical compound for treating status asthmaticus

摘要

Pharmaceutical composition comprises enoximone, which is administered intravenously in an amount of not 300 mg per day, preferably 200 mg per day. An independent claim is also included for a kit comprising the pharmaceutical composition and a drug including beta -2 sympathomimetic agent, catecholamines, aminophylline, corticosteroids, parasympatholytic agent, magnesium sulfate, ketamine and/or S-ketamine for treating status asthmaticus. ACTIVITY : Antiasthmatic. Test details are described but no results given. MECHANISM OF ACTION : None given.